ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.040
+0.075 (7.76%)
At close: Aug 25, 2026, 4:00 PM EDT
1.032
-0.008 (-0.79%)
After-hours: Aug 25, 2026, 7:30 PM EDT

ADC Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
79.5881.3670.8469.56209.9133.92
Revenue Growth
3.03%14.85%1.84%-66.86%518.89%-
Gross Profit
-9.23-26.16-43.23-60.120.15-125.48
Operating Income
-94.06-106.1-129.14-165.99-123.34-261.72
Net Income
-96.91-142.62-157.85-240.05-157.13-230.03
Earnings Per Share
-0.65-1.12-1.62-2.94-2.01-3.00
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
United States
76.7373.5569.2869.0674.91
Europe, The Middle East and Africa
2.867.811.560.5105
Total
79.5881.3670.8469.56209.91

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
219.11261.34250.87278.6326.44466.54
Total Debt
438.19439.55443.09427.95329.73327.23
Net Cash (Debt)
-219.08-178.21-192.22-149.35-3.29139.32
Net Cash Growth
------64.94%
Net Cash Per Share
-1.47-1.40-1.98-1.83-0.041.82

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-102.27-141.17-123.84-118.69-138.31-233.38
Capital Expenditures
-0.03-0.26-0.87-3.22-0.69-3.43
Free Cash Flow
-102.3-141.44-124.7-121.9-139-236.81
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-11.59%-32.16%-61.02%-86.40%9.60%-
Operating Margin
-118.19%-130.41%-182.30%-238.63%-58.76%-771.65%
Pretax Margin
-122.28%-174.06%-222.60%-288.89%-74.75%-741.53%
Profit Margin
-121.77%-175.31%-222.83%-345.11%-74.86%-678.20%
FCF Margin
-128.55%-173.85%-176.04%-175.25%-66.22%-698.20%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.645.382.721.931.4645.71